Cannapharmarx CPMD
OTC CPMD
$0.00 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Cannapharmarx, Inc. (CPMD) Cost of Revenue (2024 - 2026)

Updated

Cannapharmarx (CPMD) reported Cost of Revenue of $414,664 for Q2 2026, down 51.4% from $852,818 a year earlier and down 60.0% from the prior quarter.

Analysis

Cannapharmarx, Inc. (CPMD) Cost of Revenue (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Cannapharmarx's Cost of Revenue came in at $3.21 million, down 29.2% year-over-year; for FY2025, it came in at $3.45 million, down 8.2% from FY2024.

  • By year, Cost of Revenue came in at $3.76 million in FY2024.
  • The Q2 2026 figure ranks as the lowest quarterly Cost of Revenue since Q2 2024.
  • Year over year, Cost of Revenue gained in four of the last six quarters, with growth averaging 74.2%.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $1.04 million (Q1 2026), $659,721 (Q4 2025) and $1.1 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 414,664.00
Mar 31, 2026 1.04 Mn
Dec 31, 2025 659,721.00
Sep 30, 2025 1.10 Mn
Jun 30, 2025 852,818.00
Mar 31, 2025 837,926.00
Dec 31, 2024 2.17 Mn
Sep 30, 2024 668,322.00
Jun 30, 2024 171,364.00
Mar 31, 2024 463,248.00
API Access

Cannapharmarx, Inc. Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=CPMD&period=max&api_key=YOUR_API_KEY